Who owns FORTRESS BIOTECH INC?
- Ticker: FBIO
- CUSIP Number: 34960q307
Tip: Access positions for across all investors
Analyze quarterly positions in Fortress Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Fortress Biotech stock
Who bought or sold FORTRESS BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rosalind Advisors | 608k | $1.2M | 0% | Mar 2024 |
|
| Vanguard Group | 479k | $959k | 35% | Mar 2024 |
|
| Acadian Asset Management | 292k | $582k | 100% | Mar 2024 |
|
| Nantahala Capital Management | 278k | $556k | -25% | Mar 2024 |
|
| Shikiar Asset Management | 223k | $446k | 22% | Mar 2024 |
|
| Pvg Asset Management | 132k | $396k | 100% | Dec 2023 |
|
| Geode Capital Management | 113k | $227k | 100% | Mar 2024 |
|
| GSA Capital Partners | 107k | $215k | 100% | Mar 2024 |
|
| CI Private Wealth | 105k | $211k | -2% | Mar 2024 |
|
| Susquehanna International | 86k | $173k | 100% | Mar 2024 |
|
| Envestnet Asset Management | 81k | $161k | 100% | Mar 2024 |
|
| BlackRock | 75k | $150k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 62k | $123k | 16% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 51k | $102k | -46% | Mar 2024 |
|
| Northern Trust | 46k | $92k | 100% | Mar 2024 |
|
| Rsm Us Wealth Management | 36k | $73k | 0% | Mar 2024 |
|
| FMR | 24k | $48k | 100% | Mar 2024 |
|
| Financial Advocates Investment Management | 22k | $44k | 100% | Mar 2024 |
|
| Integrated Wealth Concepts | 20k | $40k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 18k | $35k | 4295% | Mar 2024 |
|
| PFG Investments | 16k | $33k | 100% | Mar 2024 |
|
| Cetera Investment Advisers | 16k | $32k | 100% | Mar 2024 |
|
| Virtu Financial | 15k | $31k | 100% | Mar 2024 |
|
| Gladstone Institutional Advisory | 12k | $36k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 12k | $24k | 10% | Mar 2024 |
|
| Citadel Advisors | 10k | $20k | -39% | Mar 2024 |
|
| UBS Group | 3.8k | $7.6k | 100% | Mar 2024 |
|
| Russell Investments | 2.1k | $4.2k | 0% | Mar 2024 |
|
| Morgan Stanley | 2.0k | $4.1k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 1.9k | $3.8k | -95% | Mar 2024 |
|
| Group One Trading | 896.00 | $1.8k | 100% | Mar 2024 |
|
| Bank of America Corporation | 771.00 | $1.5k | -2% | Mar 2024 |
|
| Jpmorgan Chase & Co | 672.00 | $1.3k | -48% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 376.00 | $752.000000 | 100% | Mar 2024 |
|
| Newbridge Financial Services Group | 133.00 | $266.000000 | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 33.00 | $66.000000 | 100% | Mar 2024 |
|
| Royal Bank of Canada | 19.00 | $0 | -100% | Mar 2024 |
|
| YHB Investment Advisors | 6.00 | $12.000000 | 100% | Mar 2024 |
|
| Qube Research & Technologies | 2.00 | $4.000000 | 100% | Mar 2024 |
|
Who sold out of Fortress Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hudson Bay Capital Management | Dec 2023 | 327k | $985k |
| National Asset Management | Dec 2023 | 86k | $259k |
| Jane Street | Dec 2023 | 28k | $85k |
| Wealth Management Partners | Dec 2023 | 20k | $60k |
| Simplex Trading | Dec 2023 | 1.8k | $5.0k |